Royalty Pharma Operating Lease Liability Payments - 2024 (Lessee) decreased by 1.5% to $3.72M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Higher payments indicate increased short-term cash requirements for maintaining the current operational footprint.
This represents the total cash payments expected to be made for operating leases during the 2024 fiscal year. It is a fo...
Standard disclosure; peers provide this to assist in cash flow modeling and liquidity assessment.
lease_liability_payments_2024_lessee| Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|
| Value | $3.78M | $3.78M | $3.72M |
| QoQ Change | — | +0.0% | -1.5% |